|
| | 
|
 | |
        
|  |
 
|
 Teva Pharmaceutic - [Ticker: TEVA] |     | | Last Trade | 14.01 | Last Trade Time | 2017-11-01 - 19:35:00 | | Variation | +0.21 (+1.52%) | Open | 13.55 | | High | 14.08 | Low | 13.38 | | Volume | 21,287,058 | Average Volume (3m) | 0 | | Yield | | Bid / Ask | 14.01 x 8,100 - 14.02 x 6,000 | | Former Close | 13.80 | 52 Week Range | [0.00 - 0.00] | | PER | 0.00% | EPS | 0.00 | | Ex-Dividend Date | | Dividend Payment | | | Market Capitalization | 0 | 1 Year Price-Target | 0.00 | | Note: The data may have some minutes of delay. |
| | Watch more quotes |
| Last 10 Forum Topics about Teva Pharmaceutic: | | No topics about Teva Pharmaceutic [TEVA] have been found, but a search on the Forum for more topics related to Teva Pharmaceutic is advised. |
|
News about Teva Pharmaceutic [TEVA]: (ordered by relevance)
| - Investors question green tint of Teva's $5bn sustainability bond Financial Times
- CSRWire - Teva Becomes First Pharmaceutical Company to Execute Sustainability-Linked Bond Tied to Both Climate and Access to Medicine Targets CSRwire.com
- Teva Announces Successful Upsize of Sustainability-Linked Senior Notes Offering and Pricing of $5000000000 of Sustainability-Linked Senior Notes Business Wire
- Teva to Sell Record $5 Billion of Sustainability-Linked Bonds Bloomberg
- Teva Pharmaceuticals plans $5 billion sustainability-linked bond tied to climate and access to medicine targets MarketWatch
Teva Announces Early Tender Results of its Debt Tender Offer, Increase of the Maximum Tender Amount and Election of Early Settlement Business Wire
J&J, Teva Beat $50 Billion Opioid Case in First Industry Win Bloomberg
Amgen, Biohaven, Lilly and Teva plowed plenty into marketing migraine meds. Is it working? FiercePharma
Should You Be Concerned About Teva Pharmaceutical Industries Limited's (NYSE:TEVA) ROE? Nasdaq
Worldwide Digital Dose Inhaler Industry to 2026 - Featuring Lupin, Novartis and Teva Pharmaceutical Industries Among Others PRNewswire
By selling bonds tied to drug access and climate goals, Teva takes pharma in a new direction - STAT STAT
GlaxoSmithKline LLC v. Teva Pharms. USA, Inc. | Robins Kaplan LLP - JDSupra JD Supra
From Cuyana to Teva Fast Company
3 Undervalued Warren Buffett Stocks Morningstar
Sun: TASE falls on Omicron variant concerns Globes
The Best Cyber Monday Shoe Deals (2021): Allbirds, Nike, Ugg, Tevas, and More Condé Nast Traveler
Global Autoinjectors Markets Report 2021-2026: Growing Prevalence of Targeted Therapies, Rising Incidence of Anaphylaxis, and Increasing Number of Regulatory Approvals - ResearchAndMarkets.com Business Wire
Teva halts output at U.S. drug plant after FDA flags concerns Reuters
Glaxo's Win in Case Against Teva Lifts Other Drugmakers Bloomberg
Teva Pharmaceuticals' Motion to Dismiss Denied Policy & Medicine
9 @ 9: Teva Slippers, Avoiding A 'swamp Butt' And Live Action 'Simpsons' Open | Chicago News Oakland News Now
Is A Fall Imminent For Teva Stock After Its Recent Rally? Forbes
Contraceptives Market revenue to cross USD 39 Bn by 2027: Global Market Insights Inc. GlobeNewswire
Teva must face government's kickback claims over Copaxone - judge Reuters
Why Teva Pharmaceutical Industries Shot Higher Today Motley Fool
Teva's pursuit of J&J boosted by FDA acceptance of filing for approval of long-acting schizophrenia drug FiercePharma
Fitch Affirms Teva at 'BB-'; Outlook Remains Negative Fitch Ratings
Two pharma giants claim Irish-based Teva breached its patents The Irish Times
Teva and Bioeq Announce Commercial Partnership for Biosimilar Business Wire
Brussels' Teva probe reveals dark side of patent protections Financial Times
Antitrust: Commission opens formal investigation: Teva EU News
Mylan sues generic rival Teva over 'sophisticated scheme' to block Copaxone copycats FiercePharma
EXCLUSIVE Teva Pharm unlikely to reach deals to co-produce vaccines -CEO Reuters
NRx Pharmaceuticals Identifies Significantly Higher Likelihood of Surviving and Recovering from Critical COVID-19 in ZYESAMI® (aviptadil) Treated Patients Previously Administered Remdesivir GlobeNewswire
UK and Israel join forces to stop Iran gaining nuclear weapons Telegraph.co.uk
Teva taps new North American commercial chief as key meds Ajovy, Austedo lag their rivals FiercePharma
Teva reaches $925,000 settlement to resolve drug price-fixing claims PMLiVE
Why Teva Pharmaceuticals Has Two A-Products In The Bag Seeking Alpha
AstraZeneca, Merck KGaA, Pfizer, and Teva Team up with Tech and Investment Leaders to Launch New Biotech Innovation Lab Pharmaceutical Technology Magazine
Teva to Host Conference Call to Discuss Third Quarter 2021 Financial Results at 8 a.m. ET on October 27, 2021 Business Wire
After cost-cutting spree, Teva chief Schultz nabs big pay bump to nearly $16M FiercePharma
EPR Podcast Episode 1 - Richard Daniell, Teva Pharmaceuticals European Pharmaceutical Review
AlivaMab Discovery Services Announces Multi-Target Agreement with Teva Pharmaceuticals Business Wire
Class 2 Medicines Recall: Bristol Laboratories Limited, Brown & Burk UK Ltd, Teva UK Ltd, Irbesartan-containing and Losartan-containing products, EL (21)A/14 GOV.UK
Teva, Glenmark accuse U.S. government of improperly expanding price-fixing case FiercePharma
Former Moderna CMO Zaks goes back to his Israeli roots, reemerging as Teva board director FiercePharma
Is Teva Pharmaceutical a Safe Stock to Buy Now? Motley Fool
Teva to Host Conference Call to Discuss Second Quarter 2021 Financial Results at 8 a.m. ET on July 28, 2021 Business Wire
Teva to Present New Data from Growing Mental Health Portfolio at Psych Congress 2021 Yahoo Finance
Antitrust: Commission fines Teva and Cephalon ?60.5 million EU News
Teva and MODAG Announce Licensing Collaboration for Neurodegenerative Disease Drug Candidate Yahoo Finance
Teva Announces Its Launch of the First Generic PERFOROMIST®, Formoterol Fumarate Inhalation Solution, 20 mcg/2 ML, Used to Treat Chronic Obstructive Pulmonary Disease (COPD), in the United States Business Wire
Is Teva Pharmaceutical Industries (NYSE:TEVA) Using Too Much Debt? Nasdaq
Israel-based Teva to invest $42 mln in new drug plant in Bulgaria SeeNews
Teva Announces New Environmental, Social and Governance (ESG) Strategy and Goals in 2020 Report Business Wire
No joy for Ajovy: Teva's migraine drug can't find a convincing win in meta-analysis versus Biohaven, AbbVie meds FiercePharma
What To Do After Teva Stock Falls Below $10 Again Seeking Alpha
Teva to close Sudocrem plant in Dublin, 110 jobs to go RTE.ie
Teva Pharmaceutical Industries is in talks to manufacture and distribute COVID vaccines Fortune
Teva Pharm sees growth in two main branded drugs in otherwise flat 2021 Reuters
Generic-Drug Labeling Strategy Likely to Survive Teva Rehearing Bloomberg
J&J, Teva Opioid Trial May Signal Cost of Drug Maker Accords Bloomberg
Teva recalls single lot of cancer drug topotecan after complaint flags glass particulate in vial FiercePharma
Teva Announces Post Hoc Analysis of Long-Term Data Examining Treatment with AUSTEDO® (deutetrabenazine) Tablets in Adult Patients with Tardive Dyskinesia Business Wire
Teva Announces Launch of its Generic Erythromycin Tablets USP, Used to Treat or Prevent a Variety of Bacterial Infections, in the United States Business Wire
Teva Announces Launch of First Generic Version of AZOPT® (brinzolamide ophthalmic suspension) 1%, used to treat high pressure inside the eye, in the United States Business Wire
Teva Announces Ministry of Health, Labour and Welfare Approves AJOVY® (fremanezumab) Injection in Japan for the Preventive Treatment of Migraine in Adults Business Wire
Teva to Highlight Research in Respiratory Care at Upcoming 2021 American Thoracic Society International Conference Business Wire
Pinsent Masons advises Teva Pharmaceuticals on ?84m sale of its consumer healthcare brand portfolio to Karo Pharma AB. Out-Law.com
Buffy the asthma inhaler? Teva taps 'Vampire Slayer' actress to raise inhaler misuse awareness FiercePharma
Teva Presents New Data at 7th European Academy of Neurology Congress Suggesting Socio-Economic Factors May Contribute to the Significant Under-Diagnosis of Migraine Yahoo Finance
Generic Makers to Challenge Ruling Upholding Teva Cancer Drug Bloomberg Law
On the trend trail with Teva ? sandal of the summer Drapers
Teva: Biosimilars In The US Will Become Like Complex Generics Generics Bulletin
English High Court finds Bayer patent obvious in win for Teva Life Sciences Intellectual Property Review
Teva Pharmaceutical's Ice-Cube Business Model Seeking Alpha
Teva sells its only manufacturing plant in Russia The Pharma Letter
Reflecting on Teva Pharmaceutical Industries' (NYSE:TEVA) Share Price Returns Over The Last Five Years Simply Wall St
Teva And TerraCycle Announce TevaForever Recycling Program For ?Well-Loved? Sandals Forbes
Teva to Host Conference Call to Discuss Fourth Quarter 2020 Financial Results and 2021 Financial Guidance at 8 a.m. ET on February 10, 2021 Business Wire
Showcasing Teva's Commitment to Helping Patients Have More Migraine-Free Days, 18 Abstracts will be presented, Including One Late-Breaker, on AJOVY® (fremanezumab-vfrm) Injection at the International Headache Society and European Headache Business Wire
AbbVie vs.Teva: Which Drug Manufacturing Stock is a Better Choice? Yahoo Finance
Teva Sets Ambitious Long-Term Environmental Goals As Part of CSRwire.com
LoA Update: Teva's extended-release risperidone for schizophrenia sees 5-point boost in regulatory potential following Clinical Trials Arena
Teva sees room for growth with FDA communications and complex generics, COO says Endpoints News
Teva receives EU Marketing Authorisation for Seffalair® Spiromax® and BroPair® Spiromax® (salmeterol xinafoate / fluticasone propionate) Business Wire
GSK, Teva on-again, off-again lawsuit is back on: Will 'skinny labeling' get a reprieve? FiercePharma
Teva Drug-Label Case Spurs Fresh Litigation as Judges Weigh Redo Bloomberg Law
Teva UK Enters Erectile Dysfunction Category With First Ever Rx-To-OTC Switch HBW Insight
Teva joins pharma's help-the-helpers trend with campaign for Canada's COVID caregivers FiercePharma
Teva Canada Provides New Patient Resource to Empower Those Living with Chronic Conditions Business Wire
Teva Wins New Hearing in Glaxo 'Skinny Label' Drug Patent Case Bloomberg Law
Teva Generic Price-Fixing Securities Suit Gets Class Status (1) Bloomberg Law
Teva Pharmaceutical Industries Enters Oversold Territory (TEVA) Nasdaq
Teva to Present 8 Abstracts on AJOVY® (fremanezumab-vfrm) Injection and Hold Symposium on Healthcare Disparities at WCN Yahoo Finance
Biogen sues Teva over MS generic Life Sciences Intellectual Property Review
Teva and MedinCell Announce Positive Results for Registration Trial of Investigational Extended-Release Subcutaneous Injectable Risperidone for Patients with Schizophrenia Business Wire
Teva appeals to court to keep 'incredibly damaging' Hollywood parody videos under wraps in New York opioid case Endpoints News
Teva Canada Welcomes Efforts to Address Critical Drug Supply in the Federal Budget Canada NewsWire
US FDA nod to Teva for key specialty product to weigh on Sun Pharma Business Standard
'Sole' Mates: Teva and Stance Unite, Release Faux Pas Collab GearJunkie
Teva to Present Latest Data on AJOVY® (fremanezumab-vfrm) Injection at the 2021 American Headache Society (AHS) Annual Meeting, Showcasing Teva's Longstanding Heritage in the Management of Migraine Business Wire
Teva to lay off 200 in Israel - Globes Globes
Federal Circuit Decides Teva-Lilly Spat for Antibody Compositions and Methods JD Supra
| For more news about Teva Pharmaceutic click here:
Teva Pharmaceutic News |
|
Website Width:
Background image: |
|  | |
|
|
![Teva Pharmaceutic - [Ticker: TEVA] chart](http://www.tr4der.com/chart/tr4der-TEVA-1-year.png)
